MemorialCare Heart & Vascular Institute becomes the first LA County hospital to use Cleerly AI, a tool that’s changing the face of heart disease diagnosis.
The MemorialCare Heart & Vascular Institute has taken a major leap forward in heart disease diagnosis by becoming the first hospital in Los Angeles County to integrate Cleerly AI, an innovative technology that analyzes Coronary Computed Tomography Angiography (CTA) scans to provide a more accurate picture of coronary artery plaque.
Unlocking New Insights with Cleerly AI
Developed by Cleerly, Inc., this AI-powered analysis is a game-changer for patients and healthcare professionals alike. By providing a precise measurement of total plaque volume and soft plaque, Cleerly AI offers a more nuanced understanding of coronary artery disease, enabling doctors to make more informed diagnoses and personalized treatment plans.
Traditionally, CTA scans have been limited in their ability to quantify the extent of plaque buildup in coronary arteries. This has led to a lack of standardization in diagnosis and treatment approaches, resulting in variable patient outcomes. Cleerly AI aims to bridge this gap by providing a consistent and reliable means of plaque quantification, which can help identify patients who are at high risk of cardiac events.
Quantifying Soft Plaque: A New Frontier in Heart Disease Analysis
One of the key innovations of Cleerly AI is its ability to detect and quantify soft plaque, a type of plaque that is particularly associated with increased cardiac risk. Soft plaque is often undetectable using traditional imaging techniques, making it a major challenge for healthcare professionals. By identifying and measuring soft plaque, doctors can better understand the extent of coronary artery disease and develop targeted treatment strategies to mitigate its impact.
What this means
For patients, the integration of Cleerly AI into MemorialCare’s diagnostics workflow means more accurate and informed diagnoses, leading to better treatment outcomes and improved quality of life. This technology has the potential to transform the way we approach heart disease diagnosis and treatment, enabling healthcare professionals to provide more personalized and effective care.
